The role of tegafur/uracil in pulmonary malignancy

Drugs

Volumn 58, Issue SUPPL. 3, 1999, Pages 71-75

  Langer, Corey J ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN; PYRIMIDINE; TEGAFUR; UFT; VINDESINE;

CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG BLOOD LEVEL; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; NEUTROPENIA; THROMBOCYTOPENIA;

EID: 0033512761     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958003-00010     Document Type: Conference Paper

References (15)

1. Pinedo HM, Peter FJ. Fluorouracil: biochemistry and pharmacology. J Clin Oncol 1988; 6: 1653-64
2. Pazdur R, Covington WC, Brown NS, et al. Comparative steady state pharmacokinetics of oral UFT versus protracted intravenous 5-fluoro uracil. Proc Am Soc Clin Oncol 1996; 15: 474A
3. Hirata K, Sasaki K, Yamamitsu S, et al. A comparison of 5-fluorouracil concentration of 5-fluorouracil drip infusion versus oral UFT in plasma of the same patients. Gan To Kagaku Ryoho 1993; 20: 1409-11
4. Taguchi T, Fume H, Koyama Y, et al. Phase I study of UFT. Jpn J Cancer Chemother 1980; 7: 966-72
5. Nakajimo O, Ihara K, Isoda T, et al. Phase I and II studies of mixture of 1-5 fluorouracil and uracil. Jpn J Cancer Chemother 1980; 7: 1558-60
6. Ota K, Taguchi T, Kimura K, et al. Report on nationwide pooled data and cohort investigation in UFT phase II study. Cancer Chemother Pharmacol 1988; 22: 333-8
7. Keicho N, Saijo N, Shinkai T, et al. Phase II study of UFT mixture in patients with advanced non-small cell lung cancer. Jpn J Clin Oncol 1986; 16: 143-6
8. Wada M, Hitomi S, Teramatsu T. Postoperative non-small cell lung cancer; a prospective randomized trial of cisplatin, vindesine, UFT versus UFT alone versus control. Proc Am Soc Clin Oncol 1994; 13: 1084A
9. Yamada Y, Saito H, Oie S, et al. Experimental study of the effect of combined treatment of UFT with CDDP on human solid tumor-xenografts in nude mice, Gan To Kagaku Ryoho 1990; 17: 1327-31
10. Shimizu N, Teramoto S, Hitomi S, et al. A randomized controlled post-operative adjuvant chemotherapy trial of MMC and tegafur versus MMC and UFT for adenocarcinoma of the lung - first study. Jpn J Lung Cancer 1991; 31: 1011-9
11. Wada H, Hitomi S, Teramatsu T, et al. Adjuvant chemotherapy after complete resection in non-small cell lung cancer. J Clin Oncol 1996; 14: 1048-54
12. Ichinose Y, Takanashi N. Yano T, et al. A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer. Cancer 1995; 75: 2677-80
13. Koinumaru S, Matsuda T, Saitoh J, et al. Pilot study of UFT combined with 5 consecutive days cisplatin in non-small cell lung cancer. Lung Cancer 1997; 18: 241-51
14. Niitani H, Yoshimori K, Yoneda S, et al. Phase II trial of UFT plus cisplatin in patients with advanced non-small cell lung cancer. Proc lut Assoc Study Lung Cancer 1997; 18: 56A
15. Nakazato M, Koike A, Sail S, et al. Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: a prospective randomized clinical trial. Proc Am Soc Clin Oncol 1997; 16: 990A